Methods and systems for performing thrombectomy procedures

Abstract

Devices, systems and methods are provided for performing intra-lumenal medical procedures in a desired area of the body. Thrombectomy systems and methods of performing medical procedures to re-establish the intravascular flow of blood are provided for the treatment of ischemic disease states.

Description

CROSS-REFERENCE TO RELATED APPLICATIONS[0001]This application claims the benefit of U.S. Prov. Ser. 61 / 525,362 filed Aug. 19, 2011 which is hereby incorporated by reference herein in its entirety.BACKGROUND OF THE INVENTION[0002]The field of intralumenal therapy for the treatment of vascular disease states has for many years focused on the use of many different types of therapeutic devices. While it is currently unforeseeable that one particular device will be suitable to treat all types of vascular disease states, it may however be possible to reduce the number of devices used for some disease states while at the same time improve patient outcomes at a reduced cost. To identify potential opportunities to improve the efficiency and efficacy of the devices and procedures it is important for one to understand the state of the art relative to some of the more common disease states.[0003]For instance, one aspect of cerebrovascular disease in which the wall of a blood vessel becomes weak...

AI Technical Summary

Benefits of technology

The present invention provides a thrombectomy system with a balloon member that can be inflated and expanded to restore patency of a body lumen in a mammal. The balloon member is made of a non-compliant material and has a longitudinally extending portion and a radially expanding retrieval portion. The system can be used to remove blockages in blood vessels and other body lumens, and the inflation of the balloon member can be achieved with a syringe or other inflation source. The technical effects of this invention are improved restoration of patency of body lumens and better blood flow.

Problems solved by technology

While it is currently unforeseeable that one particular device will be suitable to treat all types of vascular disease states, it may however be possible to reduce the number of devices used for some disease states while at the same time improve patient outcomes at a reduced cost.

Under cerebral flow conditions the weakened vessel wall forms a bulge or aneurysm which can lead to symptomatic neurological deficits or ultimately a hemorrhagic stroke when ruptured.

One drawback associated with the use of bare embolization coils relates to the inability to adequately pack or fill the aneurysm due to the geometry of the coils which can lead to long term recanalization of the aneurysm with increased risk of rupture.

For instance, in the case of bioactive coils, the materials eliciting the biological healing response are somewhat difficult to integrate with the coil structure or have mechanical properties incompatible with those of the coil making the devices difficult to accurately position within the aneurysm.

This expansion may be immediate or time delayed but is generally, at some point, out of the control of the physician.

With a time delayed response the physician may find that coils which were initially placed accurately and detached become dislodged during the expansion process leading to subsequent complications.

For many aneurysms, such as wide necked or fusiform aneurysms the geometry is not suitable for coiling alone.

While these stent like devices have broadened the types of aneurysms amenable to embolization therapy, utilization of these devices in conjunction with embolization devices is technically more complex for the physician, may involve more risk to the patient and have a substantial cost increase for the healthcare system.

Stent devices of this nature while having the potential to reduce treatment costs have not been realized commercially due to the difficulty in manufacturing, reliability in delivering the devices to the treatment site and an inability to properly position the denser portion of the stent device accurately over the neck of the aneurysm.

Commercial and prototype versions of these devices have shown only marginal improvements over guidewires due to an inability to adequately grasp the thrombus or to gain vascular access distal to the thrombus (i.e. distal advancement of the device pushes the thrombus distally).

While the aforementioned devices may have the ability to access the cerebrovasculature, they lack sufficient structural coverage of the lesion to achieve the desired patency of the vessel without the use of a balloon device.

Images